Cumberland Pharmaceuticals, Inc. (CPIX)
6.66
+0.86
(+14.83%)
USD |
NASDAQ |
Nov 18, 16:00
6.55
-0.11
(-1.65%)
After-Hours: 20:00
Cumberland Pharmaceuticals Price to Book Value : 1.377 for Nov. 18, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 17, 2026 | 1.199 |
| November 16, 2026 | 1.077 |
| November 13, 2026 | 1.216 |
| November 12, 2026 | 1.371 |
| November 11, 2026 | 1.266 |
| November 10, 2026 | 1.096 |
| November 09, 2026 | 1.110 |
| November 06, 2026 | 1.079 |
| November 05, 2026 | 1.036 |
| November 04, 2026 | 0.9181 |
| November 03, 2026 | 0.8912 |
| November 02, 2026 | 0.8726 |
| October 30, 2026 | 0.9698 |
| October 29, 2026 | 0.8995 |
| October 28, 2026 | 1.007 |
| October 27, 2026 | 1.024 |
| October 26, 2026 | 0.8995 |
| October 23, 2026 | 1.756 |
| October 22, 2026 | 1.754 |
| October 21, 2026 | 1.689 |
| October 20, 2026 | 1.646 |
| October 19, 2026 | 1.385 |
| October 16, 2026 | 1.485 |
| October 15, 2026 | 1.559 |
| October 14, 2026 | 1.549 |
| Date | Value |
|---|---|
| October 13, 2026 | 1.483 |
| October 12, 2026 | 1.448 |
| October 09, 2026 | 1.454 |
| October 08, 2026 | 1.443 |
| October 07, 2026 | 1.425 |
| October 06, 2026 | 1.476 |
| October 05, 2026 | 1.466 |
| October 02, 2026 | 1.528 |
| October 01, 2026 | 1.553 |
| September 30, 2026 | 1.619 |
| September 29, 2026 | 6.573 |
| September 28, 2026 | 6.633 |
| September 25, 2026 | 6.539 |
| September 24, 2026 | 6.882 |
| September 23, 2026 | 6.822 |
| September 22, 2026 | 7.046 |
| September 21, 2026 | 6.522 |
| September 18, 2026 | 6.290 |
| September 17, 2026 | 6.178 |
| September 16, 2026 | 5.997 |
| September 15, 2026 | 5.705 |
| September 14, 2026 | 5.757 |
| September 11, 2026 | 5.490 |
| September 10, 2026 | 5.568 |
| September 09, 2026 | 5.404 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.497 |
| Corcept Therapeutics, Inc. | 8.883 |
| Veru, Inc. | 1.388 |
| Johnson & Johnson | 8.089 |
| Eli Lilly & Co. | 32.31 |
Price to Book Value Related Metrics
| PS Ratio | 3.991 |
| PEG Ratio | -0.0354 |
| Price | 6.66 |
| Earnings Yield | -11.86% |
| Market Cap | 99.85M |
| PEGY Ratio | -0.0354 |